Get the Stockscreener App
9.94
0.20%
0.02
Engene Holdings Inc stock is traded at $9.94, with a volume of 181.27K.
It is up +0.20% in the last 24 hours and up +19.76% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$9.92
Open:
$9.88
24h Volume:
181.27K
Relative Volume:
0.15
Market Cap:
$665.83M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-2.1608
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+12.19%
1M Performance:
+19.76%
6M Performance:
+173.08%
1Y Performance:
+56.54%
1-Day Range:
$9.785
$10.16
1-Week Range:
$8.95
$10.20
52-Week Range:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
9.94 | 664.49M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | Jefferies | Buy |
| Nov-11-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
10 Best Low Volatility Canadian Stocks to Buy - Insider Monkey
Aug Final Week: Can enGene Holdings Inc Equity Warrant lead its sector in growthJuly 2025 Analyst Calls & Safe Entry Point Identification - baoquankhu1.vn
enGene CEO Talks Detalimogene for Community Urology as LEGEND Study Hits Full Enrollment - MarketBeat
How does enGene Holdings Inc compare to its peersWeekly Trade Report & Weekly High Return Stock Forecasts - baoquankhu1.vn
Retail Trends: Will enGene Holdings Inc stock hit new highs in YEARJuly 2025 Earnings & Fast Moving Trade Plans - baoquankhu1.vn
Levels Update: Will enGene Holdings Inc stock benefit from M AJuly 2025 Rallies & Expert Approved Trade Ideas - baoquankhu1.vn
enGene CEO to Highlight Genetic Medicine Strategy at Guggenheim Biotech Summit 2026 - The Globe and Mail
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - BioSpace
enGene to Spotlight Bladder Cancer Gene Therapy at Guggenheim Biotech Summit 2026 - TipRanks
Pharma News: How does enGene Holdings Inc compare to its peersTrade Ideas & Long-Term Capital Growth Ideas - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Growth Report: Can enGene Holdings Inc benefit from deglobalizationJuly 2025 Trends & Weekly High Return Stock Forecasts - baoquankhu1.vn
Insider Sell: Can SAIHEAT Limited Equity Warrant be recession proofPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Is enGene Holdings Inc a stock for growth or value investors2025 Market Outlook & AI Driven Stock Reports - baoquankhu1.vn
enGene (NASDAQ:ENGN) Shares Up 8.1%What's Next? - MarketBeat
Portfolio Shifts: Is enGene Holdings Inc a stock for growth or value investorsQuarterly Market Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease - Yahoo Finance
Retail Trends: Is enGene Holdings Inc Equity Warrant stock a value trap2025 Big Picture & Low Drawdown Trading Techniques - baoquankhu1.vn
Macro Review: Is The Gabelli Healthcare Wellness Trust exposed to political riskWeekly Trade Review & Advanced Technical Analysis Signals - baoquankhu1.vn
Targets Report: Is VTMX a top pick in the sectorMarket Performance Report & Low Risk Entry Point Guides - baoquankhu1.vn
Jefferies initiates coverage on Engene stock with Buy rating By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Shares Gap UpHere's What Happened - MarketBeat
Jefferies Financial Group Initiates Coverage on enGene (NASDAQ:ENGN) - MarketBeat
Jefferies Initiates Coverage on enGene With Buy Rating, $28 Price Target - marketscreener.com
Jefferies initiates coverage on Engene stock with Buy rating - Investing.com
Is enGene Holdings Inc. Equity Warrant impacted by rising ratesJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
enGene (NASDAQ:ENGN) Shares Down 5.7%Here's Why - MarketBeat
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene Holdings Closes $130 Million Public Offering - MSN
EnGene extends momentum with another 14% surge on Friday - MSN
Trend Recap: Is HBTA a cyclical or defensive stockMarket Growth Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
enGene (NASDAQ:ENGN) Reaches New 12-Month High – Time to Buy? - Defense World
Short Squeeze: Is enGene Holdings Inc stock a good dividend stockJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
enGene extends momentum with another 14% surge on Friday (ENGN:NASDAQ) - Seeking Alpha
enGene (NASDAQ:ENGN) Hits New 1-Year HighStill a Buy? - MarketBeat
Profit Recap: What analysts say about enGene Holdings Inc Equity Warrant stockPortfolio Risk Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
enGene (NASDAQ:ENGN) Stock Price Up 11.3%Time to Buy? - MarketBeat
Aug Reactions: Is Heritage Financial Corporation a speculative investmentWeekly Risk Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Strong Trading VolumeWhat's Next? - MarketBeat
enGene Holdings (NASDAQ: ENGN) adds $125M debt facility and new warrants - Stock Titan
Breakout Watch: Is enGene Holdings Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - PharmiWeb.com
Weekly Trades: Does enGene Holdings Inc Equity Warrant stock benefit from AI growth2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital - citybiz
enGene Holdings Secures $125 Million Loan Agreement with Hercules Capital - Intellectia AI
Meme Stocks: Is enGene Holdings Inc benefiting from interest rate changesJuly 2025 Rallies & Verified Entry Point Signals - baoquankhu1.vn
Is enGene Holdings Inc. a strong growth stockPortfolio Allocation Tips & Free Tap Rapid Wealth - bollywoodhelpline.com
Targets Report: Will HITI benefit from geopolitical trendsQuarterly Market Review & Safe Capital Preservation Plans - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Up 32.4% in December - MarketBeat
Aug Summary: Will PCRX announce a stock splitAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):